Levels of Exon-Skipping Are Not Artificially Overestimated Because of the Increased Affinity of Tricyclo-DNA-Modified Antisense Oligonucleotides to the Target DMD Exon
Nucleic Acid Therapeutics · 2024
DOI: 10.1089/nat.2024.0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2024. Verfasst von Mathilde Doisy und 3 weiteren Autor:innen. Beteiligte Einrichtung: UVSQ, Inserm, END-ICAP, Université Paris-Saclay, Versailles, France. Hauptthemen laut MEDLINE: Exons, Oligonucleotides, Antisense, Muscular Dystrophy, Duchenne, Dystrophin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UVSQ, Inserm, END-ICAP, Université Paris-Saclay, Versailles, France.
ORCID-Profile: Aurélie Goyenvalle
Zitieren
APA
Doisy, M., Vacca, O., Saoudi, A., & Goyenvalle, A. (2024). Levels of Exon-Skipping Are Not Artificially Overestimated Because of the Increased Affinity of Tricyclo-DNA-Modified Antisense Oligonucleotides to the Target DMD Exon. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2024.0002
Vancouver
Doisy M, Vacca O, Saoudi A, Goyenvalle A. Levels of Exon-Skipping Are Not Artificially Overestimated Because of the Increased Affinity of Tricyclo-DNA-Modified Antisense Oligonucleotides to the Target DMD Exon. Nucleic Acid Therapeutics. 2024. doi:10.1089/nat.2024.0002
BibTeX
@article{Doisy2024,
author = {Doisy, Mathilde and Vacca, Ophélie and Saoudi, Amel and Goyenvalle, Aurélie},
title = {Levels of Exon-Skipping Are Not Artificially Overestimated Because of the Increased Affinity of Tricyclo-DNA-Modified Antisense Oligonucleotides to the Target DMD Exon},
journal = {Nucleic Acid Therapeutics},
year = {2024},
doi = {10.1089/nat.2024.0002}
}
EUVIMED